USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: CELLEX, INC.
City: ROCKVILLE
State: MD
Zip+4: -
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $2,729,487.00 11
SBIR Phase II $1,999,981.00 1

Award List:

Rapid Detection of Bacterial Contamination in Platelets

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Xingxiang Li
Award Amount: $99,670.00
Abstract:
DESCRIPTION (provided by applicant): Sepsis resulted from transfusion of bacterially contaminated blood components, particularly platelets, is an on-going medical problem that frequently causes mortality or serious morbidity. The incidence of bacterially contaminated platelets and red cells is 1 in… More

A Simple, Sensitive and Accurate HIV-1 Viral Load Test

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Xingxiang Li
Award Amount: $299,693.00
Abstract:
DESCRIPTION (provided by applicant): Monitoring HIV viral load, or the concentration of viral RNA in the plasma, is part of the standard care of HIV-infected individuals. Since HIV viral load is indicative of current virologic status, it is used as a marker for disease progression and… More

A Rapid, Sensitive and Fully Automated Y. pestis Test

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: Xingxiang Li
Award Amount: $549,084.00
Abstract:
DESCRIPTION (provided by investigator): The 2001 Anthrax attack confirmed that bioterrorism is a real possibility. Although the attack occurred at a small scale, its impact reached terror proportion. Unfortunately, as former Senator Warren Rudman pointed out, "the likelihood of a terrorist attack… More

A Novel Method for Efficient and Specific Nucleic Acid Isolation

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: DHS
Principal Investigator: Xing-Xiang Li
Award Amount: $100,000.00
Abstract:
We propose to develop a novel reagent for nucleic acid isolation. If successfully developed, this reagent will be appropriate for use in nucleic acids isolation from a variety of sample types, including environmental samples. The most advantageous characteristic of this reagent is its specific… More

A Rapid, Sensitive and Fully Automated Anthrax Test

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Xingxiang Li
Award Amount: $584,115.00
Abstract:
DESCRIPTION (provided by applicant): Bioterrorism and biowarfare are a threat for our nation. Such threat became reality in the 2001 Anthrax attack. Although the attack occurred at a small scale, its impact reached terror proportion. Unfortunately, as former Senator Warren Rudman pointed out, "the… More

Rapid Detection of Catheter Related Bacteraemia

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Xingxiang Li
Award Amount: $151,662.00
Abstract:
DESCRIPTION (provided by applicant): Central venous catheterization is an essential part of intensive care and cancer patient care. Approximately 5 million central venous catheters are used each year in the U.S., and the number is expected to rise due to aging population. However, the major risk of… More

An Affinity Column for Influenza Virus Vaccine Manufacturing

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Xingxiang Li
Award Amount: $224,784.00
Abstract:
DESCRIPTION (provided by applicant): We have found a polymer that specifically and efficiently binds to influenza viruses. When coupled to a solid support such as magnetic particles or agarose, the polymer could be used to isolate and concentrate flu virus from a large volume sample. One… More

A Reagent for Rapid and Effective Virus Isolation and Concentration

Award Year / Program / Phase: 2007 / SBIR / Phase I
Agency: HHS
Principal Investigator: Xingxiang Li
Award Amount: $173,396.00
Abstract:
DESCRIPTION (provided by applicant): Current global efforts to confront the HIV/AIDS epidemic focus on the prevention of new infections and the care for those who are living with HIV. Highly active antiretroviral therapy (HAART) which has dramatically imp roved the outlook of HIV/AIDS patients is… More

A Rapid and Sensitive Flu Virus Test

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: USDA
Principal Investigator: Xing-Xiang (Jam Li, CSO
Award Amount: $79,948.00
Abstract:
Avian influenza is a highly contagious disease that can spread rapidly in a susceptible population. Thus, avian influenza may have devastating effects on the poultry industry. Because of potential interspecies transmission, as evidenced with the avian influenza virus H5N1, avian influenza may have… More

An Assay for Rapid and Sensitive Flu Virus Detection

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator: Xingxiang Li
Award Amount: $196,100.00
Abstract:
DESCRIPTION (provided by applicant): The specific aims of this Phase I SBIR proposal are to determine the feasibility of a novel detection technology for rapid and sensitive detection of influenza virus. Specifically, we will determine if the manual assay is rapid (about 15 minutes), sensitive (as… More

A Novel Influenza Neuraminidase Inhibition Assay

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Xingxiang Li
Award Amount: $271,035.00
Abstract:
DESCRIPTION (provided by applicant): The primary goal of the Phase I SBIR projects is to determine the feasibility of a novel neuraminidase assay to be used as an influenza neuraminidase inhibition and drug susceptibility assay. The proposed assay is a bio chemiluminescence assay that uses a novel… More

Point of Care Flu Drug Resistance Test

Award Year / Program / Phase: 2010 / SBIR / Phase II
Agency: HHS
Principal Investigator: Xingxiang Li
Award Amount: $1,999,981.00
Abstract:
DESCRIPTION (provided by applicant): The studies from our Phase I SBIR (AI082728-01) demonstrated that it is feasible to develop the proposed assay, a biochemiluminescence assay that uses a novel flu virus neuraminidase substrate, for sensitive detection o f influenza virus drug resistance. The… More